Herein, interestingly, we observed that the miRNA hsa-miR-19a-3p is downregulated in OS-R, and the existing literature suggests that it is often associated with cancer progression; importantly, one of its targets is AKT, which is extensively implicated in cancer and drug resistance. Here, AKT1 is linked to cancer.